EDSA Edesa Biotech Inc
Company Analysis
Latest News
Edesa Biotech Shrugs Off an Earnings Miss to Rally on a Vitiligo Trial Milestone — But Can $10 Million in Cash Fund the Bet?
Shares shifted as Edesa Biotech (EDSA) jumped 8.3% to $5.88 in after-hours trading on August 13, despite posting a wider-than-expected quarterly loss....
🟢 Edesa Biotech is trading 8.3% up in after-hours trading after EB06 Phase 2 site activation
Edesa Biotech is trading 8.29% up at $5.88, with the after-hours gain appearing driven by completed preparations and site activation for the Phase 2 EB06...
Edesa Biotech third quarter 2026 loss of $0.60 per share misses analyst estimates
Edesa Biotech reported a net loss of $5.4 million for the third quarter of 2026, widening significantly from the prior year as the company ramped up clinical...
Edesa Biotech Inc Q2 2026 Earnings Preview: What Analysts Expect on August 14, 2026
Edesa Biotech Inc is expected to report zero revenue and a consensus EPS loss of -$0.44 for the quarter ending June 30, 2026, with its $5.72 stock price...
🔴 Edesa Biotech is trading 8.33% down in after-hours trading with no clear company-specific catalyst
Edesa Biotech is trading at $5.06, down 8.33%, with no clear Edesa Biotech-specific announcement identified for August 11, 2026. - Its official news page was...
🟢 Edesa Biotech is trading 5.59% up today after argenx agreed to acquire Forte Biosciences
Edesa Biotech is trading at $5.53, up +5.59% on August 11, 2026, as investors respond positively to immunology-sector deal activity. - argenx agreed to...
🟢 Edesa Biotech is trading 7.06% up in pre-market after argenx's $2.2 billion Forte acquisition
Edesa Biotech is trading 7.06% up in pre-market at $5.61 after positive immunology-sector sentiment linked to argenx’s approximately $2.2 billion acquisition...
🟢 Edesa Biotech is trading 6.87% up in after-hours trading after argenx’s $2.2 billion Forte acquisition
Edesa Biotech is trading 6.87% up now at $5.60 after positive immunology-sector sentiment linked to argenx’s agreement to acquire Forte Biosciences for...
🟢 Edesa Biotech is trading 5.69% up today after argenx’s $2.2 billion Forte acquisition
Edesa Biotech is trading 5.69% up now at $5.57, continuing positive biotech-sector sentiment linked to argenx’s $2.2 billion acquisition of Forte...
🟢 Edesa Biotech is trading 5.54% up today amid biotech-sector strength after argenx’s Forte acquisition
Edesa Biotech is trading at $5.33 (+5.54%), with the move appearing primarily sector-driven amid stronger biotech sentiment following argenx’s $2.2 billion...
🟢 Edesa Biotech is trading 8.1% up in pre-market; no company-specific catalyst identified
Edesa Biotech is trading 8.12% up at $5.46 after no clear company-specific announcement was identified for August 7, 2026. - Its official news page lists...
🟢 Edesa Biotech is trading 5.3% up today in a thin-liquidity rebound with no clear catalyst
Edesa Biotech is trading at $5.44 (+5.29%) in after-hours trading in what appears to be a thin-liquidity rebound following a regular session close of $5.17. •...
🟢 Edesa Biotech is trading 5.3% up today in after-hours trading on light news flow
Edesa Biotech is trading at $5.44 (up 5.3%) in after-hours sessions, rebounding from a 3.5% regular-session drop to $5.17 on August 5, 2026. • The move occurs...
🟢 Edesa Biotech is trading 5.8% up today, rebounding in after-hours on light news flow
Edesa Biotech is trading at $5.47 (5.8%) up in after-hours, rebounding from a 3.5% regular-session decline to $5.17 on light news flow. • The move lacks a...
🔴 Edesa Biotech is trading 5.8% down today on profit-taking following a multi-day rebound
Edesa Biotech is trading 5.8% down today at $5.05 as investors lock in gains following a sharp multi-day recovery. • The downward move appears to be driven by...
🟢 Edesa Biotech is trading 8.6% up today as technical rebound continues amid broader biotech rally
Edesa Biotech is trading 8.6% up at $5.82 as it extends a technical rebound following a thinly traded selloff in late July. • The move occurs in the absence...
🟢 Edesa Biotech is trading 5.6% up today on technical rebound amid broader market rally
Edesa Biotech is trading 5.6% up at $5.53 today, staging a technical rebound following recent volatility and a thinly traded selloff. • No fresh...
🔴 Edesa Biotech is trading 6.5% down today as technical pressure extends last week's selloff
Edesa Biotech is trading 6.5% down at $4.89 in pre-market, extending last week’s volatility-driven selloff in the thinly traded biotech name. • The move...
🔴 Edesa Biotech is trading 5.1% down today as technical pullback continues
Edesa Biotech is trading 5.1% down today at $4.85 as the stock continues a volatility-driven pullback noted late last week. • The move appears to be a...
🔴 Edesa Biotech is trading 6.9% down today, extending a volatility-driven pullback
Edesa Biotech is trading 6.9% down today at $4.89 as the stock extends a volatility-driven pullback following a sharp rebound earlier in the week. • The move...